Antonia Busse

Antonia Busse

Charité Universitätsmedizin Berlin - Berlin / Germany
Others
AD Scientific Index ID: 1756452
Charité - Medical University of Berlin
person_outline Antonia Busse's MOST POPULAR ARTICLES
1-) A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDSU Keilholz, A Letsch, A Busse, AM Asemissen, S Bauer, IW Blau, ...Blood, The Journal of the American Society of Hematology 113 (26), 6541-6548, 20093572009
2-) Expression of the stem cell markers nestin and CD133 on circulating melanoma cellsA Fusi, U Reichelt, A Busse, S Ochsenreither, A Rietz, M Maisel, ...Journal of Investigative Dermatology 131 (2), 487-494, 2011822011
3-) Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunitsA Busse, M Kraus, IK Na, A Rietz, C Scheibenbogen, C Driessen, IW Blau, ...Cancer: Interdisciplinary International Journal of the American Cancer …, 2008842008
4-) Role of TGF-β in melanomaA Busse, U KeilholzCurrent pharmaceutical biotechnology 12 (12), 2165-2175, 2011842011
5-) Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanomaR Schuster, NE Bechrakis, A Stroux, A Busse, A Schmittel, ...Clinical cancer research 13 (4), 1171-1178, 2007842007